Recently, researches have confirmed that the glucagon-like peptide 1 (GLP-1) plays an important role in treating degenerative diseases of the central nervous system such as Alzheimer, Parkinson, and vascular dementia, and thus could improve the patients' cognitive function [8]. The gene discussed is GCG; the disease is Parkinson disease.